| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |